Status:
RECRUITING
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Prostatic Cancer
Prostatic Neoplams
Eligibility:
MALE
18+ years
Brief Summary
Background: Prostate cancer is one of the most common cancers for men in the U.S. There are some new ways to take pictures of the cancer. There are also new ways to use image-guided biopsy and therap...
Detailed Description
Background: * Multiparametric MRI (mpMRI) has become an established method for localizing clinically significant prostate cancer, and identification of imaging-based prognostic markers represents an ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients with an increased risk for prostate cancer (strong family history and/or germline mutation in DNA repair genes), or with a diagnosis of prostatic cancer or suspicious for prostatic cancer lesions.
- Age greater than or equal to 18 years
- Ability of subject to understand and the willingness to sign a written informed consent document.
- EXCLUSION CRITERIA:
- none
Exclusion
Key Trial Info
Start Date :
February 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2033
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT03354416
Start Date
February 26 2018
End Date
December 31 2033
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892